Atlas company financials

Hims & Hers Health, Inc.

Standardized 7-year financial series for Hims & Hers Health, Inc., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001773751FY2019 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$2.3B

Adjusted EBITDA

—

Net result

$128.4M

Net financial debt

—

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$599M

TTM revenue

$2.1B

TTM free cash flow

—

Latest quarter net result

$15.8M

Quarterly coverage: 18 periods · latest quarter FY2025-Q3 · TTM revenue growth 107.2%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
primary · hims-hers-health-inc-fy2019 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2022-02-24 · Retrieved: 2026-04-26T11:50:39.454169+00:00
SEC EDGAR companyfacts
us-gaap:CashAndCashEquivalentsAtCarryingValue · us gaap companyfacts · primary · hims-hers-health-inc-fy2019 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2020-03-27 · Retrieved: 2026-04-26T11:50:39.454169+00:00
SEC EDGAR companyfacts
us-gaap:OperatingIncomeLoss · us gaap companyfacts · primary · hims-hers-health-inc-fy2020 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2021-03-22 · Retrieved: 2026-04-26T11:50:39.454169+00:00
SEC EDGAR companyfacts
us-gaap:CapitalExpendituresIncurredButNotYetPaid · us gaap companyfacts · comparative · hims-hers-health-inc-fy2021 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2024-02-26 · Retrieved: 2026-04-26T11:50:39.454169+00:00
SEC EDGAR companyfacts
primary · hims-hers-health-inc-fy2022 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2023-02-27 · Retrieved: 2026-04-26T11:50:39.454169+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2019	83M	—	-74M	-72M	-75M	—	—	missing accounts receivable · missing adjusted ebitda · missing capex · missing free cash flow · missing inventory · missing net financial debt · missing research and development
FY2020	149M	—	-5M	-3M	-777K	—	—	comparative annual fact carried from later 10k · missing adjusted ebitda · missing capex · missing free cash flow · missing net financial debt · missing research and development
FY2021	272M	—	-115M	-108M	-34M	0	—	missing adjusted ebitda · missing net financial debt · missing research and development
FY2022	527M	—	-69M	-66M	-27M	0	—	missing adjusted ebitda · missing interest expense · missing net financial debt · missing research and development · missing sg and a
FY2023	872M	—	-29M	-24M	73M	-3M	—	missing adjusted ebitda · missing interest expense · missing net financial debt · missing research and development · missing sg and a
FY2024	1B	—	62M	126M	251M	-8M	—	missing adjusted ebitda · missing interest expense · missing net financial debt · missing research and development · missing sg and a
FY2025	2B	—	106M	128M	300M	-25M	—	missing adjusted ebitda · missing interest expense · missing net financial debt · missing research and development · missing sg and a

Filing provenance